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fMRICognitive control deficits have been consistently documented in patients with schizophrenia. Recent work in
cognitive neuroscience has hypothesized a distinction between two theoretically separable modes of cogni-
tive control—reactive and proactive. However, it remains unclear the extent to which these processes are
uniquely associated with dysfunctional neural recruitment in individuals with schizophrenia. This functional
magnetic resonance imaging (fMRI) study utilized the color word Stroop task and AX Continuous Perfor-
mance Task (AX-CPT) to tap reactive and proactive control processes, respectively, in a sample of 54 healthy
controls and 43 patients with first episode schizophrenia. Healthy controls demonstrated robust dorsolateral
prefrontal, anterior cingulate, and parietal cortex activity on both tasks. In contrast, patients with schizophre-
nia did not show any significant activation during proactive control, while showing activation similar to con-
trol subjects during reactive control. Critically, an interaction analysis showed that the degree to which
prefrontal activity was reduced in patients versus controls depended on the type of control process engaged.
Controls showed increased dorsolateral prefrontal cortex (DLPFC) and parietal activity in the proactive com-
pared to the reactive control task, whereas patients with schizophrenia did not demonstrate this increase.
Additionally, patients' DLPFC activity and performance during proactive control was associated with disorga-
nization symptoms, while no reactive control measures showed this association. Proactive control processes
and concomitant dysfunctional recruitment of DLPFC represent robust features of schizophrenia that are also
directly associated with symptoms of disorganization.
© 2013 The Authors. Published by Elsevier Inc. All rights reserved.1. Introduction
While decades of research illustrate that schizophrenia is associated
with deficits across a wide variety of cognitive domains, including at-
tention, memory, and language, recent theories propose that impaired
cognitive control-related dysfunction of the prefrontal cortex may ac-
count for many of these findings (Barch and Ceaser, 2012; Lesh et al.,
2011). Cognitive control involves online maintenance of goals and
task sets to guide adaptive behavior (Miller and Cohen, 2001). An ex-
tensive literature suggests that patients with schizophrenia show cog-
nitive control deficits (Cohen and Servan-Schreiber, 1992; Cohen et
al., 1996, 1999; Servan-Schreiber et al., 1996) associated with impairederms of the Creative Commons
tribution, and reproduction in
re credited.
Center, 4701 X Street, Suite E,
(C.S. Carter).
blished by Elsevier Inc. All rights rerecruitment of the dorsolateral prefrontal cortex (DLPFC) and related
circuitry, including the anterior cingulate cortex (ACC) and parietal cor-
tex (Barch et al., 2001; MacDonald and Carter, 2003; MacDonald et al.,
2000; Yoon et al., 2008).
Recent work highlights a distinction between proactive and reactive
modes of cognitive control, which Braver and colleagues have termed
the dual mechanisms of control (DMC) theory (Braver et al., 2007,
2009). Proactive control is conceptualized as maintenance of goal-
relevant information to optimally bias attention, perception and re-
sponse preparation ahead of a cognitively demanding event. In contrast,
reactive control reflects transient, ‘on thefly’ engagement of control pro-
cesses at the onset of challenging task demands. Due to its connectivity
with sensorimotor regions, DLPFC plays a central role in the mainte-
nance of goals and rules for action (Asaad et al., 2000; Watanabe,
1990, 1992), which should be reflected in increased DLPFC activity dur-
ing proactive control. Proactive control may depend more on the ability
to mount a sustained pattern of neural activity, a well-characterized as-
pect of prefrontal cortex that is observed during both physiological re-
cording in non-human primates (Goldman-Rakic, 1995) and fMRI inserved.
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associated with more transient neural engagement of not only DLPFC,
but also ACC, which is associated with detecting conflict and recruiting
DLPFC engagement on a trial to trial basis (Egner and Hirsch, 2005;
Kerns et al., 2005; MacDonald et al., 2000). Edwards et al. (2010)
investigated proactive and reactive control processes in patients with
schizophrenia using a version of the AX Continuous Performance Task
(AX-CPT), in which the cue (proactive control) and probe (reactive con-
trol) phases were examined separately. Patients with schizophrenia
showedmore probe-related activity while controls demonstrated great-
er cue-related PFC activity, suggesting that patients were relying on re-
active control. Further, after training patients to recognize and attend
to contextual information, they showed a significant shift in brain activa-
tion (i.e., increased cue-related activity and decreased probe-related ac-
tivity) reflecting changing emphasis from reactive to proactive control.
While these data provide evidence for the dissociation between
proactive and reactive control, examining these processes within
the same task has some limitations. First, reactive control is necessar-
ily linked to contextual processes engaged during the cue, thus the re-
active control measure is inherently confounded by the degree to
which proactive processes are engaged. This might attenuate reactive
activity in controls due to their intact proactive processes. While this
may be unavoidable for any task, as individuals often engage context
maintenance to guide responding, this limitation may be partially
mitigated by choosing tasks specifically biased towards one type of
control process. The B-cue trials of the AX-CPT offer an excellent ex-
ample of proactive control (see Fig. 1 for AX-CPT illustration). During
the AX-CPT, subjects make a target response to the probe letter X,
onlywhen it follows the cue letter A. All other trials in which X is pre-
ceded by any letter other than A (collectively referred to as B-cue tri-
als) require a non-target response. B-cue trials require preparation to
inhibit a prepotent response due to the high proportion of AX (target)
trials, as one must prepare to inhibit the incorrect, but more frequent,
response in order to correctly respond to the subsequent probe letter.
In contrast, the single trial Stroop task is uncued and can be biased to-
wards reactive control by decreasing the frequency of Incongruent
stimuli (i.e., the word RED printed in green ink). Frequent Congruent
trials permit the subject to rely more on word reading to respond
quickly and accurately; however, when an infrequent Incongruent
stimulus is presented, the subject must react quickly to engage con-
trol mechanisms to avoid reading the word and making an error
[for review see Botvinick et al., 2001]. In the current study, we lever-
age these task properties by using the AX-CPT task and color naming
Stroop task to compare proactive and reactive control processes in
patients with schizophrenia.Fig. 1. Task parameters for the a) AX-CPT and b) Stroop. Tasks were presented using E-prim
puter. Presentation of stimuli was pseudorandom, and the first two stimuli for each subjecBehaviorally,we anticipate that patientswith schizophreniawill dem-
onstrate specific deficits on the AX-CPT (i.e., reduced accuracy on AX and
BX trials with intact performance on AY and BY), aswell as reduced accu-
racy on Incongruent compared to Congruent trials on the Stroop task
when compared to healthy controls. Critically, we also predict that
schizophrenia participantswill showmore pronounced behavioral deficits
on measures of proactive (AX-CPT) compared to reactive (Stroop) con-
trol. With regard to neural recruitment, we hypothesize that schizophre-
nia participants will demonstrate reduced activation of DLPFC during the
AX-CPT (Cue B minus Cue A contrast), which loads on proactive control,
with relatively intact PFC recruitment during reactive control in the
Stroop task (Incongruent minus Congruent contrast) when compared to
control subjects. Given previous findings of reduced conflict-related ac-
tivity in the ACC during the Stroop task (Kerns et al., 2005), we also antic-
ipate that schizophrenia individuals will show lower ACC activity to
conflict stimuli compared to controls. Finally, previous literaturehas iden-
tified a relationship between cognitive control impairment anddisorgani-
zation symptoms (Barch et al., 1999a,b; Woodward et al., 2003; Yoon et
al., 2008). We hypothesize that proactive control in particular, as mea-
sured by AX-CPT behavioral performance and associated blood oxygena-
tion level dependent (BOLD) activity in DLPFC, will be more strongly
associated with schizophrenia disorganization symptoms.
2. Material and methods
2.1. Participants
Forty-three first episode patientswith schizophrenia spectrumdisor-
ders (see Table 1 for diagnoses and medication status at time of testing)
were recruited along with 54 control subjects. Of the present sample, 16
schizophrenia and 19 control participants were included in a previous
study focused only on the AX-CPT (Yoon et al., 2008). Schizophrenia par-
ticipants were outpatients within one year of their first psychotic epi-
sode. All participants were assessed using the Structured Clinical
Interview for the DSM-IV-TR [SCID-I/P; First et al., 2002]. Clinical inter-
views were conducted by clinicians with masters or doctoral degrees
trained to high reliability (kappa > .70; range = .70–1.0). Schizophre-
nia participants were followed longitudinally and diagnoses were con-
firmed 6 months after ascertainment. Clinical ratings were collected in
the schizophrenia sample using the Scale for the Assessment of Negative
Symptoms [SANS; Andreasen, 1983], Scale for the Assessment of Positive
Symptoms [SAPS; Andreasen, 1984], and Brief Psychiatric Rating Scale
[BPRS; Lukoff et al., 1986]. Three schizophrenia participants had missing
data on the SAPS and were not included in symptom analyses using
those items (e.g., disorganization). Exclusion criteria for both groupse software (http://www.pstnet.com/eprime.cfm) running on an IBM-compatible com-
t were target (AX) trials for the AX-CPT and Congruent trials for the Stroop.
Table 1
Demographic, clinical, and behavioral characteristics for patients with schizophrenia
and healthy controls.
Characteristic Schizophrenia
(n = 43)
Healthy control
(n = 54)
Years of education: mean ± SD
(range)
12.67 ± 1.91 (9–17) 14.09 ± 2.02 (10–20)⁎
Years of parental education:
mean ± SD (range)
14.87 ± 2.30 (10–19) 14.28 ± 2.44 (8–20)
Gender: n males (%) 34 (79%) 35 (65%)
Ethnicity: n Caucasian (%) 22 (51%) 28 (52%)
Handedness: n left-handed (%) 0 (0%) 4 (7%)
WASI IQ: mean ± SD (range) 102.12 ± 13.10
(78–131)
113.63 ± 10.67
(85–135)⁎
Diagnosis: n (%)
Schizophrenia 41 (96%) –
Schizoaffective 1 (2%) –
Schizophreniform 1 (2%) –
Medication status: n (%)
Unmedicated 15 (35%) –
Atypical antipsychotic 27 (63%) –
Typical and atypical
antipsychotic
1 (2%) –
Symptom scores: mean ± SD
(range)
Disorganization symptoms 7.03 ± 3.53 (3–16) –
Reality distortion symptoms 16.07 ± 6.18 (4–29) –
Poverty symptoms 13.49 ± 5.69 (3–26) –
Behavioral data
AX-CPT accuracy: mean ± SD
AX .94 ± .08 .98 ± .03
AY .82 ± .21 .84 ± .19
BX .86 ± .14 .94 ± .08
BY .98 ± .04 .99 ± .03
AX-CPT reaction time: mean
(ms) ± SD
AX 613 ± 184 545 ± 122
AY 774 ± 180 711 ± 148
BX 761 ± 302 625 ± 219
BY 664 ± 224 560 ± 164
Stroop accuracy: mean ± SD
Congruent .97 ± .03 .99 ± .02
Incongruent .92 ± .11 .95 ± .06
Stroop reaction time: mean
(ms) ± SD
Congruent 685 ± 131 622 ± 85
Incongruent 785 ± 158 717 ± 120
SD, standard deviation.
⁎ p b 0.05.
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below 70, alcohol or drug dependence or abuse within 3 months before
testing, positive urine toxicology screen for illicit drugs, prior head trau-
maworse than aGrade I concussion, or contraindication toMRI scanning.
Healthy controls were excluded for the following additional criteria: any
lifetime diagnosis of an Axis I or Axis II disorder or any first-degree rela-
tives with a psychotic disorder. Before testing, a detailed description of
the study was provided and written informed consent obtained. The
study was approved by the University of California, Davis Institutional
Review Board. Subjects completed the AX-CPT and Stroop task during
one fMRI session, with the order counterbalanced across subjects. All
subjects were paid for their participation.2.2. Measures and data analysis
Task parameters and visual depictions of the AX-CPT and Stroop
are presented in Fig. 1. Briefly, in the AX-CPT, subjects make a target
response (index finger button press) to the probe letter X only if it
was preceded by the cue letter A. All cues and non-target probes re-
quire non-target responses (middle finger button press). Target se-
quence trials are frequent and set up a prepotent tendency to makea target response when the probe letter X occurs. As a result,
non-target sequence trials where any non-A cue (collectively called
B-cues) is presented and followed by a probe letter X, require the
most cognitive control. In the Stroop task, stimuli consisted of one
of three color words (RED, GREEN, and BLUE) that were written in
one of three color inks (red, green, and blue). Stimuli could be Con-
gruent (word and ink match) or Incongruent (word and ink do NOT
match). Subjects respond with a button press corresponding to the
color of the ink of the word.
AX-CPT accuracy and reaction time were examined using ANOVA
with task condition (AX, AY, BX, BY) as a within-subjects factor and di-
agnosis as a between-subjects factor. Accuracy and reaction times were
based upon probe responses, which were only analyzed if the subject
responded correctly to the cue. D-prime context (d′-context) (Cohen
et al., 1999; Swets and Sewall, 1963) was computed from AX hits and
BX false alarms and analyzed using an independent samples t-test.
Stroop accuracy and reaction time were analyzed using ANOVA with
task (Congruent, Incongruent) as a within-subjects factor and diagnosis
as a between-subjects factor. To evaluate whether the degree of group
differences depended upon the task, difference scores were calculated
for each task [i.e., raw AX percent correct (hits) minus BX percent
error (false alarms) and Congruent percent correct minus Incongruent
percent error] and evaluated in a 2 × 2 ANOVA. Although d′-context
is computed to provide continuity with previous studies of the
AX-CPT, these raw difference scores provide a similarly derived mea-
sure of specific control processes that can be used to compare the
AX-CPT to the Stroop. To address concerns that these raw score differ-
ence values may not be directly comparable, z-transformed difference
scores were created using the entire sample and also evaluated in a
2 × 2 ANOVA. Group comparisons onmeasures that violated sphericity
assumptions were adjusted using Greenhouse–Geisser and tests in
which equal variances were not assumed.
Notably, comparing two tasks and identifying potential differen-
tial deficits in a patient group may be confounded by differences in
the measurement properties of the tasks (Chapman and Chapman,
1973, 1978). Therefore, estimates of true score variance for each
task and trial type in the control group were computed and compared
using the methods described by Chapman and Chapman (1978) in
which true score variance is the product of the reliability of the test
(coefficient alpha) and the variance of the observed scores.
2.3. Functional imaging parameters and data analysis
Imaging data were obtained using a 1.5 T General Electric MRI scan-
ner. Coplanar T1-weighted and T2-weighted structural images were ac-
quired prior to each fMRI sequence. For the AX-CPT, T2*-weighted
echoplanar imaging (EPI) sessionswere acquiredwith the following set-
tings: TR = 2000-msec, echo time = 40-msec, flip angle = 90°, and
field of view = 22 cm. Functional images consisted of 24 contiguous
and interleaved 4.0-mm axial slices with a 3.4-mm2 in-plane resolution.
For the Stroop Task, T2*-weighted EPI sessions were acquired with the
following settings: TR = 1500-msec, echo time = 32-msec, flip
angle = 90°, and field of view = 22 cm. Functional images consisted
of 20 contiguous and interleaved 4.0-mm axial slices with a 3.4-mm2
in-plane resolution and extended 80 mm above to 16 mm below the
anterior–posterior commissure line. Preprocessing was completed
using Statistical Parametric Mapping-8 (SPM8, http://www.fil.ion.ucl.
ac.uk/SPM8), including slice timing correction, spatial realignment, spa-
tial normalization to the EPIMontreal Neurological Institute (MNI) tem-
plate using a rigid-body transformation followed by non-linearwarping,
and spatial smoothingusing aGaussian 8-mm full-width half-maximum
kernel. Individual fMRI runs were removed from the analysis if transla-
tional movement exceeded 4-mm or rotational movement exceeded
3° of within-run movement.
Functional imaging analysis was performed for both event-related
tasks in SPM8 with multiple regression in the general linear model
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sponses were included in the reported contrasts. AX-CPT regressors
included the A cue, B cue, and each probe (i.e., AX, AY, BX, BY),
while Stroop regressors included Congruent and Incongruent trials.
Translational and rotational movement data were included as
covariates. Group-level random-effect comparisons were performed
between groups for the AX-CPT contrast subtracting the A cue from
the B cue regressor (AX-CPT B–A contrast) and Stroop task contrast
subtracting the Congruent from Incongruent regressor (Stroop I–C
contrast). All between-group contrasts were thresholded at the
voxel level with p b 0.01 and clusters were considered significant if
they survived cluster level FWE correction of p b 0.05. To examine
the interaction between task and group, a mixed-model ANOVA was
implemented in SPM8 with task as the within-subject factor
(AX-CPT B–A contrast and Stroop I–C contrast) and diagnosis as the
between-subject factor.
In addition to whole-brain analyses, a priori hypotheses regarding
the DLPFC and ACC prompted interrogation of two regions of interest
(ROI). The DLPFC ROI consisted of a bilateral Brodmann Area 46
anatomical mask obtained from the Wake Forest University PickAtlas
(Maldjian et al., 2003, 2004). The second ROI was obtained using
bilateral anterior cingulate regions defined in the Automated Anatomi-
cal Labeling (AAL) atlas (Tzourio-Mazoyer et al., 2002), with pre-genual
portions manually removed to isolate dorsal ACC. Beta weights for each
ROI were extracted and analyzed from the AX-CPT B–A and Stroop I–C
contrasts and evaluated in separate 2 × 2 ANOVAs with diagnosis and
task as between- and within-subjects factors, respectively. Given the a
priori directional hypothesis that patients would show attenuated ac-
tivity specifically on the Stroop task in the ACC, a one-tailed t-test was
used to test for group differences on this measure. Additionally, in
order to accurately interpret patterns of activity in the whole-brain
group by task analysis, beta weights were extracted post-hoc from re-
gions surviving whole-brain FWE correction.
2.4. Correlation analyses with clinical symptomatology
Planned bivariate correlations (two-tailed, alpha set at p b 0.05)
were performed between composite symptom measures [disorganiza-
tion, reality distortion, and poverty symptoms; see Barch et al., 2003]
and cognitive/physiologicalmeasures (AX-CPT and Stroop accuracy dif-
ference scores, DLPFC and ACC beta weights for AX-CPT B–A and Stroop
I–C contrasts). Steiger's Z tests (one-tailed)were performed to compare
correlations between tasks. Steiger's Z is preferred over Fisher's Z-test as
Steiger's Z takes into account the dependency of correlation coefficients
that have an index in common (i.e., comparing correlation coefficients
between disorganization and an AX-CPT variable to disorganization
and a Stroop variable).
3. Results
3.1. Demographic results
Participant demographic information is presented in Table 1. The
groups did not differ significantly on age, gender, handedness, or pa-
rental education. Control subjects completed more years of education
(t = 3.521, p = 0.001) and had higher estimated IQ (t = 4.724,
p b 0.001) than schizophrenia participants.
3.2. Behavioral results
See Table 1 for behavioral data. ForAX-CPT accuracy, ANOVA revealed
significant main effects of diagnosis, F(1, 95) = 7.61, p = 0.007; and
condition, F(3, 93) = 48.43, p b 0.001; and a significant diagnosis by
condition interaction, F(3, 93) = 3.58, p = 0.017. Bonferroni-corrected
(adjusted alpha level of 0.0125 per test) post-hoc comparisons of individ-
ual trial types revealed the predicted pattern of performance, withpatients showing worse performance on AX (t = 2.77, p = 0.008) and
BX (t = 3.29, p = 0.002), but not on AY (t = 0.569, p = 0.571), or BY
(t = 1.61, p = 0.112). Independent sample t-test of d′-context scores
revealed significantly lower d′-context in patients with schizophrenia
(t = 4.22, p b 0.001). ANOVA of reaction time data revealed a significant
main effect of diagnosis F(1, 95) = 6.14, p = 0.015; a significantmain ef-
fect of condition, F(3, 93) = 170.18, p b 0.001; and a trend level diagno-
sis by condition interaction, F(3, 93) = 2.45, p = 0.068. Bonferroni-
corrected (adjusted alpha level of 0.0125 per test) post-hoc reaction
time comparisons for each condition revealed a trend towards longer
reaction times for schizophrenia patients on BX (t = 2.48, p = 0.015)
and BY (t = 2.55, p = 0.013), with no significant differences on AX
(t = 2.10, p = 0.039) or AY trials (t = 1.84, p = 0.070).
For Stroop accuracy, ANOVA revealed significant main effects of di-
agnosis, F(1, 95) = 4.89, p = 0.029; and condition, F(1, 95) = 38.49,
p b 0.001; but no significant diagnosis by condition interaction, F(1,
95) = 1.62, p = 0.206. ANOVA of reaction time data revealed a signif-
icant main effect of diagnosis, F(1, 95) = 7.24, p = 0.008; a significant
main effect of condition, F(1, 95) = 211.02, p b 0.001; but no signifi-
cant diagnosis by condition interaction, F(1, 95) = 0.13, p = 0.721. In
other words, patients demonstrated lower accuracy and longer reaction
times overall compared to controls, but the extent of the performance
decrement was not dependent upon the trial type.
ANOVA of accuracy difference scores for the AX-CPT (AX hits minus
BX false alarms) and Stroop (Congruent correctminus Incongruent incor-
rect) revealed significant main effects of diagnosis, F(1, 95) = 15.73,
p b 0.001; and task, F(1, 95) = 16.56, p b 0.001; and a significant diag-
nosis by task interaction, F(1, 95) = 6.82, p = 0.010 (Fig. 3a).
Z-transformed difference scores were complicated by the presence of
outliers. Consequently, a Winsorizing procedure (Dixon, 1960; Hastings
et al., 1947) was applied to values exceeding the 99th percentile.
ANOVA of these z-transformed difference scores revealed a significant
main effect of diagnosis, F(1, 95) = 14.386, p b 0.001; no main effect
of task, F(1, 95) = 0.157, p = 0.692; and a significant diagnosis by task
interaction, F(1, 95) = 3.97, p b 0.050. While the z-transformed mea-
sure paralleled the rawdifference scoremeasure in terms of amain effect
of group and group by task interaction, the main effect of task was not
replicated. These results are encouraging and suggest that when
z-transformed, the difference scores reflect comparable levels of cogni-
tive control difficulty overall, but still reveal an interaction such that pa-
tients with schizophrenia show a decline in performance in the
proactive compared to reactive condition. Given that the z-transformed
and raw difference scores showed similar results in the interaction, raw
difference scores were used for correlation analyses.3.3. True score variance measurement
Overall, across all trial types, AX-CPT true score variance
(σ2T = 64.30) was markedly similar to Stroop true score variance
(σ2T = 69.98). Examining individual trial types for the AX-CPT,
AX trials showed the highest true score variance (σ2T = 23.86),
followed byAY (σ2T = 7.58), BX (σ2T = 2.74), andBY (σ2T = 0.25) tri-
als. For Stroop, Congruent trials (σ2T = 22.81) showed slightly higher
true score variance than Incongruent trials (σ2T = 15.76). Given that
our main comparisons of interest involve AX hits versus BX false posi-
tives in the AX-CPT and Congruent correct versus Incongruent errors,
true score variance values for these trial types are the most critical.
While AX and Congruent true score variance estimates are very similar,
Incongruent true score variance is over five times larger than BX true
score variance. Given that tasks with greater true score variance are
more likely to (erroneously) show greater differential deficits, the fact
that BX trials show lower true score variance argues against the possibil-
ity that AX-CPT specific deficits (and relatively intact Stroop perfor-
mance) in patients with schizophrenia is due purely to differences in
measurement properties of the tasks.
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3.4.1. Within-group analyses
Table 2 summarizes data for regions with significant activation,
while Fig. 2 illustrates uncorrected whole-brain results. In the AX-CPT
B–A contrast, controls showed activation in the predicted network of
frontal and parietal regions, including bilateral DLPFC, bilateral parietal
cortex, and anterior cingulate/supplementary motor area. In contrast,
patients did not demonstrate significant suprathreshold activation in
this contrast, although they did show activation across this network at
lower, uncorrected thresholds.
In the Stroop I–C contrast, controls showed robust activation in
many regions typically activated during cognitive control, including bi-
lateral DLPFC, anterior cingulate/supplementarymotor area, and left pa-
rietal cortex. Patients showed a similar pattern of activation, including
bilateral DLPFC, bilateral parietal cortex, and anterior cingulate/supple-
mentary motor area.
To evaluate the potential impact of medication on brain activity,
individuals who were currently taking antipsychotic medication
were compared to unmedicated subjects at both a priori regions of in-
terest. There was no significant effect of medication on DLPFC activity
during the AX-CPT (t = 1.63, p = 0.120; Cue B minus Cue A), DLPFCTable 2
Regions of significant activation (height p b 0.01; FWE cluster corrected p b 0.05).
MNI coordinates
Region Brodmann's area x y z T voxel
AX-CPT B–A contrast
Control
L superior parietal cortex 7 −50 −70 50 5.77
R DLPFC 9 52 12 36 5.68
R inferior parietal cortex 40 50 −44 50 5.63
L DLPFC 46 −48 32 24 5.42
L inferior parietal cortex 40 −44 −52 42 5.32
R superior parietal cortex 7 34 −68 44 5.27
R DLPFC 46 56 28 28 5.2
R ACC/SMA 32/8 2 22 48 4.27
Schizophrenia
No significant clusters
Control > schizophrenia
R inferior parietal cortex 40 52 −46 48 4.02
R DLPFC 9/46 54 28 34 3.37
Schizophrenia > control
No significant clusters
Stroop I–C contrast
Control
L DLPFC 9 −48 10 30 8.85
L inferior parietal cortex 40 −32 −58 52 7.23
L ACC/SMA 32/8 −2 16 58 6.7
L inferior parietal cortex 40 −38 −50 50 6.01
R DLPFC 46 44 24 26 6.16
Schizophrenia
L DLPFC 9 −48 4 36 7.76
R DLPFC 9 42 12 36 6.77
R DLPFC 46 40 36 28 6.01
L superior parietal cortex 7 −28 −58 48 5.7
R superior parietal cortex 7 32 −60 54 5.48
L ACC/SMA 32/8 −2 16 52 4.91
Control > schizophrenia
No significant clusters
Schizophrenia > control
No significant clusters
AX-CPT B–A > Stroop I–C
Control > schizophrenia
L DLPFC 9 −22 20 40 4.07
R inferior parietal cortex 40 52 −46 48 3.78
R DLPFC 9 36 38 38 3.73
Schizophrenia > control
No significant clusters
MNI, Montreal Neurological Institute; DLPFC, dorsolateral prefrontal cortex; ACC, ante-
rior cingulate cortex; SMA, supplementary motor area; R, right; L, left.activity during the Stroop (t = 0.71, p = 0.483; Incongruent minus
Congruent), ACC activity during the AX-CPT (t = 1.58, p = 0.121),
or ACC activity during the Stroop (t = 0.32, p = 0.753; Incongruent
minus Congruent).
3.4.2. Between-group analyses
In the whole-brain AX-CPT B–A contrast, control subjects demon-
strated significantly more activity in right DLPFC as well as right infe-
rior parietal cortex compared to patients. Similarly, control subjects
demonstrated significantly more activity in the a priori DLPFC ROI
compared to patients with schizophrenia (t = 2.45, p = 0.016; Cue
B minus Cue A). No significant differences were found in the a priori
structurally defined dorsal ACC ROI for the AX-CPT B–A contrast
(t = 1.28, p = 0.205; Cue B minus Cue A). No clusters reached signif-
icance in the whole-brain between-group comparison of the Stroop I–
C contrast. However, the a priori structurally defined dorsal ACC ROI
revealed a trend towards greater activity in controls compared to pa-
tients in the primary Stroop contrast (t = 1.42, p = .080; Incongru-
ent minus Congruent). No significant difference was identified in
the DLPFC ROI for the Stroop task (t = 0.47, p = 0.643; Incongruent
minus Congruent).
3.4.3. Task by group analyses
The whole-brain task by group interaction analysis revealed signifi-
cant clusters in bilateral DLPFC and right inferior parietal cortex, with
control subjects showing greater increases in activation in the AX-CPT
B–A contrast compared to the Stroop I–C contrast, while patients with
schizophrenia did not (Fig. 4a). This pattern of results was corroborated
in the a priori DLPFC ROI (Fig. 3c), which revealed a significant group by
task interaction, F(1, 95) = 6.66, p = 0.011; a trend level main effect of
group, F(1, 95) = 3.64, p = 0.059; and no significant main effect of
task, F(1, 95) = 1.30, p = 0.257. The a priori ACC ROI revealed no
group by task interaction, F(1, 95) = 0.044, p = 0.834; a trend level
main effect of group, F(1, 95) = 3.88, p = 0.052; and no significant
main effect of task, F(1, 95) = 1.80, p = 0.183. To accurately interpret
activity in regions surviving FWE correction in the whole-brain task by
group interaction, we also evaluated beta weights extracted from the
local maximum coordinates in each significant region (left and right
DLPFC and right parietal cortex; see Table 2 for coordinates and Fig. 4
for graphs). Left DLPFC revealed a significant group by task interac-
tion, F(1, 95) = 15.91, p b 0.001; a trend level main effect of
group, F(1, 95) = 2.93, p = 0.090; and no significant main effect
of task, F(1, 95) = 1.48, p = 0.227. Right DLPFC revealed a signif-
icant group by task interaction, F(1, 95) = 10.72, p = 0.001; a
main effect of group, F(1, 95) = 4.69, p = 0.033; and no signifi-
cant main effect of task, F(1, 95) = 2.05, p = 0.155. The right infe-
rior parietal ROI revealed a significant group by task interaction,
F(1, 95) = 10.74, p = 0.001; a significant main effect of group,
F(1, 95) = 9.05, p = 0.003; and no significant main effect of
task, F(1, 95) = 1.89, p = 0.173. In contrast there were no regions
in the whole-brain interaction analysis in which patients demon-
strated greater increases than controls.
3.5. Associations with clinical symptomatology
Bivariate correlations in the patient group examined the relation-
ship between performance (i.e., AX hits minus BX false alarms and
Congruent hits minus Incongruent errors) and DLPFC activity (proac-
tive and reactive). Better AX-CPT performance was significantly asso-
ciated with higher proactive DLPFC activity (Cue B minus Cue A),
r(43) = 0.343, p = 0.025, while Stroop performance was not signif-
icantly associated with reactive DLPFC activity (Incongruent minus
Congruent), r(43) = −0.228, p = 0.141. No relationships were
found with ACC activity. Lower disorganization symptomatology
was associated with a higher AX-CPT accuracy difference score,
r(40) = −0.56, p b 0.001, as well as higher BOLD recruitment in
Fig. 2.Within- and between-group results for AX-CPT B–A contrast and Stroop I–C contrast at an uncorrected threshold of p b .01 (for display purposes) in healthy control subjects
and schizophrenia patients.
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(Fig. 5). There was no association between disorganization and the
Stroop accuracy difference score or BOLD in DLPFC or ACC during
the Stroop (all p > 0.12; Incongruent minus Congruent).
Steiger's Z transformations determined whether disorganization
symptoms were more strongly associated with performance and
DLPFC activity on the AX-CPT (Cue B minus Cue A) compared to the
Stroop (Incongruent minus Congruent). Behavioral performance on
the AX-CPT showed a significantly stronger relationship to disorgani-
zation, compared to the relationship between Stroop performance
and disorganization (p = 0.03). There was not a significant differ-
ence in the strength of the relationship between disorganizationFig. 3. a) Accuracy difference scores representing the group by task interaction, inwhichpatient
in proactive (AX-CPT = AX Hits minus BX False Alarms) compared to reactive (Stroop = Cong
DLPFC ROI. c) Beta values (AX-CPT B–A and Stroop I–C) from a priori bilateral DLPFC ROI repreand DLPFC activity during the AX-CPT compared to the Stroop task
(p = 0.28). Notably, the relationship between disorganization and
proactive control processes was specific in that correlations with real-
ity distortion, r(42) = −0.108, p = 0.50, and poverty symptoms,
r(43) = −0.131, p = 0.40, were low.
4. Discussion
Weused twowell-validated cognitive paradigms to probe the neural
substrates supporting reactive and proactive control processes in a large
sample of patients with first episode schizophrenia. Behaviorally, pa-
tients with schizophrenia generally demonstrated worse performanceswith schizophrenia demonstrate a greater decrease inperformance compared to controls
ruent Hits minus Incongruent Errors) control. b) Horizontal slice view of a priori bilateral
senting the group by task interaction. Error bars reflect standard error of the mean.
Fig. 4. a) Whole-brain thresholded at p b .01 representing the group by task interaction, in which healthy controls (HC) demonstrate greater increases than patients (SZ) in BOLD
activity in proactive (AX-CPT B–A) compared to reactive (Stroop I–C) control. The subsequent column graphs represent beta values from the three significant FWE cluster corrected
regions representing the group by task interaction: b) inferior parietal cortex, c) right DLPFC, and d) left DLPFC.
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mance decrement was much larger for the proactive control measure
examining AX hits and BX false alarms compared to the reactive control
measure examining Congruent correct and Incongruent error trials.
Neuroimaging results revealed robust activation in both reactive and
proactive tasks in healthy controls, represented by lateral prefrontal
(BA9, BA46, ACC), and inferior parietal regions during the Stroop I–C
contrast and prefrontal (BA9, BA46, ACC) and parietal cortex during
the AX-CPT B–A contrast. While patients demonstrated activity compa-
rable to controls in the Stroop, activitywasmarkedly reduced during the
AX-CPT, with no activity surviving the cluster-wise threshold. More im-
portantly, the interaction analysis of group and task showed that con-
trols increased activity in DLPFC as well as inferior parietal cortex
during proactive compared to reactive control, while patients did not
show this increase. Taken together these results suggest that schizo-
phrenia individuals demonstrate relatively preserved engagement of
the fronto-parietal network during reactive control, but show a reduced
ability to increase recruitment in DLPFC and parietal cortex for proactive
control.
Additionally, we identified significant relationships between disor-
ganization and both performance and reduced DLPFC activity during
proactive control (AX-CPT B–A contrast). These data corroborate the
previous work identifying a relationship between disorganization and
DLPFC activity (Edwards et al., 2010) and DLPFC connectivity (Yoon et
al., 2008). In contrast, no significant relationships were found between
disorganization and any metric of reactive control (e.g., Stroop perfor-
mance, DLPFC I–C activity, or ACC I–C activity). Furthermore, the rela-
tionship between disorganization and AX-CPT performance was
stronger than the relationship to Stroop performance, suggesting that
disorganization is more strongly associated with proactive control pro-
cesses. These data, taken in the context of the existing literature, suggest
that while reactive control deficits have been identified on the Stroop
[for review see Henik and Salo, 2004], proactive control processes may
be a more robust link to disorganized clinical symptomatology and un-
derlying neuropathophysiology.These data shed additional light on the pathophysiology of impaired
cognition in schizophrenia in several ways. First, they add to an already
substantial literature identifying DLPFC impairment in schizophrenia
[see Glahn et al., 2005; Minzenberg et al., 2009 for meta-analytic re-
views]. Consistent with recent work (Edwards et al., 2010; Perlstein et
al., 2003; Yoon et al., 2008), between-group comparisons revealed sig-
nificantly reduced DLPFC recruitment during the AX-CPT in schizophre-
nia individuals. Our findings of adequate recruitment of DLPFC and trend
level hypoactivation of ACC during reactive control must be considered
in the context of some inconsistency in the literature, with some studies
of the Stroop revealing PFC hyperactivation in patients (Weiss et al.,
2003) and others identifying PFC hypoactivation (Carter et al., 1997;
Yucel et al., 2002). These inconsistencies may partly be the result of var-
iability in task design, with some studies including neutral stimuli, pre-
sentation in block- or event-related designs, and modifications of the
task in which the subject has to explicitly identify whether the word
and color are congruent or not as opposed to identifying the ink color
with a response. Stage of illness may also play a role as we have previ-
ously reported robust ACCdecreases using a similar design to thepresent
study in chronic patients (Kerns et al., 2005). Second, our data provide
additional support for the dual mechanisms of control theory proposed
by Braver et al. (2007). Notably, these data suggest relatively intact reac-
tive control in patients with schizophrenia and imply that prefrontal
control deficits in schizophrenia reflect a stronger loading on proactive
control processes, reflected in decreased fronto-parietal recruitment. Re-
duced recruitment of PFC is consistentwith themodel we presented in a
recent review, which theoretically links cellular abnormalities in the PFC
with altered inter-regional cortical connectivity, cognitive control dys-
function, and disorganization (Lesh et al., 2011). Sustained activity in
the PFC in non-human primates performing working memory tasks de-
pends upon both dopamine (DA) and norepinephrine (NE), modulating
neuronal activity through D1 and alpha 2 adrenergic receptors, respec-
tively (Arnsten and Li, 2005; Arnsten et al., 1988; Brozoski et al., 1979;
Cai and Arnsten, 1997). GABA-ergic interneurons are also integral to
this process (Gonzalez-Burgos et al., 2010; Lewis et al., 2008). The
Fig. 5. Correlations between disorganization symptom scores in patients with schizophrenia and a) AX-CPT accuracy difference score, b) DLPFC mean beta values during the AX-CPT
task (B–A contrast), c) Stroop accuracy difference score, and d) DLPFC mean beta values during the Stroop task (I–C contrast).
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tivity needed for proactive control may be particularly disrupted in
schizophrenia. Treatments that remediate these processes, including
those that target catecholaminergic and GABA-ergic function in local cir-
cuits in this region of the brain, remain promising as interventions to en-
hance cognitive function in schizophrenia.
One limitation of the current study is the potential effect of med-
ication on fMRI measures. Current evidence suggests that medication
effects are not the primary contributor to reduced prefrontal BOLD re-
sponse during higher-order cognition (Honey et al., 1999; Snitz et al.,
2005). Additionally, in the present study, there were no differences
between medicated and unmedicated patients in DLPFC and ACC ac-
tivity across tasks. Finally, since the patients in the present study
were very early in the course of illness, it is likely that decreased
BOLD response of DLPFC during proactive control is robust and
unrelated to the long-term effects of medication exposure or illness
chronicity. Another potential limitation is the use of two different
tasks, which may have differences in measurement properties that
complicate interpretation of a differential deficit. To examine this
issue, true score variance values were computed for each task and
found to be markedly similar. Furthermore, when examining trial
types that were most critical to evaluating proactive and reactive con-
trol (i.e., trial types used to compute difference measures), results in-
dicated that Incongruent trials on the Stroop had much higher truescore variance than BX trials on the AX-CPT. These data suggest that
patients should be more likely to show a performance deficit on the
reactive contrast of interest, which contradict our findings of more
pronounced proactive deficits, and provide some evidence that our
results are not due to differences in measurement properties of the
tasks. Finally, differences in scanning parameters between the
AX-CPT and Stroop raises the concern that reduced coverage and/or
a decreased signal-to-noise ratio (SNR) in the Stroop may have
influenced the results. In terms of coverage, within-group results for
the Stroop show full coverage of PFC and parietal regions and only
voxels that are present in all subjects across both tasks are included
in the ANOVA. Differences in the TR and TE raise potential concerns
about differences in SNR between the tasks. Although a theoretical
SNR can be calculated, it remains difficult to quantify the end result
of a lowered TR (which should lower SNR) and a lower TE (which
should raise SNR) in the Stroop compared to the AX-CPT. While
there may be concerns about decreased SNR in the Stroop, both
groups showed robust activation on the Stroop I–C contrast, with
peak T-values much higher than the AX-CPT B–A contrast. Additional-
ly, our main findings represent a group by task interaction primarily
driven by lower activity in the schizophrenia sample during the
AX-CPT with high and relatively comparable activity in the Stroop
for both groups. We might anticipate lower SNR in the Stroop to con-
tribute to a main effect of task. However, there was no main effect of
598 T.A. Lesh et al. / NeuroImage: Clinical 2 (2013) 590–599task present in the whole-brain ANOVA or any of the a priori or
post-hoc ROIs. Consequently, it would be unlikely for these differ-
ences in scanning parameters to account for the specific pattern of re-
sults we present.
4.1. Conclusions and future directions
In summary, the current study contributes to our understanding of
cognitive control deficits in schizophrenia by highlighting dissociable
processes that provide a more precise understanding of the cognitive
and neural mechanisms underlying impaired cognition in the illness.
Results suggest that proactive control and associated fronto-parietal
dysfunction may represent a more robust marker of disease pathology
associated with the clinical presentation of the disorder (i.e., disorgani-
zation) in first episode patients. Future studiesmay leverage these find-
ings by tailoring cognitive training paradigms, neurostimulation and
medication development to specifically target proactive control mecha-
nisms in the prefrontal cortex. Future studies should also explore how
stage of illness plays a role in the integrity of proactive and reactive con-
trol since alterations in elements of reactive control such as the ACC ap-
pear more robust in published studies involving chronic patients.
Finally, future studies should focus on whether this profile of more pro-
nounced proactive control deficits is also present in other psychiatric
populations (i.e., mood disorders and autism) who present with im-
paired cognitive control (Pompei et al., 2011; Solomon et al., 2009;
Strakowski et al., 2005; Wagner et al., 2006).
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